How Sponsors And CROs Can Use Direct Patient Feedback To Improve Trial Engagement

For those of us working in the clinical trial industry, we know just how critical research is to improve the future of human health. But is that feeling shared by the public at large? According to the 2021 CISCRP study, the answer is a resounding “yes.”

In the study, 97% of survey respondents believe that clinical research studies are important to the discovery and development of new medicines. Notably, respondents from Europe are significantly more likely to report that clinical studies are “very important” compared to other regions.

Altruism is one of the driving forces for participation, with the greatest benefits for taking part being cited as “helping to advance science and the treatment of my disease/condition” and “helping to save or improve the lives of other patients with my disease/condition.”

Another critical factor is representation; 97% of respondents felt that it was important for clinical research studies to include a diverse group of study participants who will ultimately reflect the therapy being tested. The majority additionally indicated that knowing the study staff was representative of diverse communities was also very important.

When looking into the experiences of those who have participated in research in the past, some interesting observations surface.